Sharma Abhinav, Raman Vishnu, Lee Jungwoo, Forbes Neil S
Department of Chemical Engineering, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Molecular and Cellular Biology Graduate Program, University of Massachusetts, Amherst, Massachusetts 01003, United States.
ACS Infect Dis. 2022 May 13;8(5):969-981. doi: 10.1021/acsinfecdis.1c00530. Epub 2022 Apr 11.
The balance of microbial species in the intestine must be maintained to prevent inflammation and disease. Healthy bacteria suppress infection by pathogens and prevent disorders such as inflammatory bowel diseases (IBDs). The role of mucus in the relation between pathogens and the intestinal microbiota is poorly understood. Here, we hypothesized that healthy bacteria inhibit infection by preventing pathogens from penetrating the mucus layer and that microbial imbalance leads to inflammation by promoting the penetration of the mucosal barrier. We tested this hypothesis with an in vitro model that contains mucus, an epithelial cell layer, and resident immune cells. We found that, unlike probiotic bacteria, penetrated the mucosal layers and induced the production of interleukin-8 (IL-8) and tumor necrosis factor (TNF)-α. At ratios greater than 10:1, probiotic bacteria suppressed the growth and penetration of and reduced the production of inflammatory cytokines. Counterintuitively, low densities of healthy bacteria increased both pathogen penetration and cytokine production. In all cases, mucus increased penetration and the production of cytokines. These results suggest that mucus lessens the protective effect of probiotic bacteria by promoting barrier penetration. In this model, a more imbalanced microbial population caused infection and inflammation by selecting pathogens that are more invasive and immunogenic. Combined, the results suggest that the depletion of commensal bacteria or an insufficient dosage of probiotics could worsen an infection and cause increased inflammation. A better understanding of the interactions between pathogens, healthy microbes, and the mucosal barrier will improve the treatment of infections and inflammatory diseases.
必须维持肠道微生物种类的平衡以预防炎症和疾病。健康的细菌可抑制病原体感染并预防诸如炎症性肠病(IBD)等疾病。黏液在病原体与肠道微生物群关系中的作用尚不清楚。在此,我们假设健康细菌通过阻止病原体穿透黏液层来抑制感染,而微生物失衡则通过促进黏膜屏障的穿透导致炎症。我们使用包含黏液、上皮细胞层和常驻免疫细胞的体外模型来验证这一假设。我们发现,与益生菌不同,[病原体名称未给出]穿透黏膜层并诱导白细胞介素-8(IL-8)和肿瘤坏死因子(TNF)-α的产生。当比例大于10:1时,益生菌抑制[病原体名称未给出]的生长和穿透,并减少炎性细胞因子的产生。与直觉相反,低密度的健康细菌会增加病原体的穿透和细胞因子的产生。在所有情况下,黏液都会增加[病原体名称未给出]的穿透和细胞因子的产生。这些结果表明,黏液通过促进屏障穿透削弱了益生菌的保护作用。在这个模型中,微生物群更不平衡会通过选择更具侵袭性和免疫原性的病原体导致感染和炎症。综合来看,结果表明共生细菌的减少或益生菌剂量不足可能会使感染恶化并导致炎症加剧。更好地理解病原体、健康微生物和黏膜屏障之间的相互作用将改善感染和炎症性疾病的治疗。